- Home
- KZIA vs LCFY Comparison
KZIA vs LCFY Comparison
Compare KZIA & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZIA
- LCFY
- Stock Information
- Founded
- KZIA 1994
- LCFY 2009
- Country
- KZIA Australia
- LCFY Australia
- Employees
- KZIA N/A
- LCFY N/A
- Industry
- KZIA Biotechnology: Pharmaceutical Preparations
- LCFY
- Sector
- KZIA Health Care
- LCFY
- Exchange
- KZIA Nasdaq
- LCFY Nasdaq
- Market Cap
- KZIA 9.0M
- LCFY 9.2M
- IPO Year
- KZIA 1999
- LCFY 2022
- Fundamental
- Price
- KZIA $7.20
- LCFY $5.47
- Analyst Decision
- KZIA Strong Buy
- LCFY
- Analyst Count
- KZIA 3
- LCFY 0
- Target Price
- KZIA $16.00
- LCFY N/A
- AVG Volume (30 Days)
- KZIA 299.1K
- LCFY 143.9K
- Earning Date
- KZIA 11-14-2025
- LCFY 11-11-2025
- Dividend Yield
- KZIA N/A
- LCFY N/A
- EPS Growth
- KZIA N/A
- LCFY N/A
- EPS
- KZIA N/A
- LCFY N/A
- Revenue
- KZIA $1,549,158.00
- LCFY $2,231,313.00
- Revenue This Year
- KZIA N/A
- LCFY N/A
- Revenue Next Year
- KZIA $49.25
- LCFY N/A
- P/E Ratio
- KZIA N/A
- LCFY N/A
- Revenue Growth
- KZIA 248983.08
- LCFY N/A
- 52 Week Low
- KZIA $2.86
- LCFY $2.51
- 52 Week High
- KZIA $39.05
- LCFY $13.98
- Technical
- Relative Strength Index (RSI)
- KZIA 43.08
- LCFY 39.77
- Support Level
- KZIA $6.20
- LCFY $7.07
- Resistance Level
- KZIA $7.61
- LCFY $7.67
- Average True Range (ATR)
- KZIA 0.48
- LCFY 0.82
- MACD
- KZIA -0.06
- LCFY -0.13
- Stochastic Oscillator
- KZIA 47.57
- LCFY 38.53
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
About LCFY Locafy Limited
Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.